A case series of post COVID-19 mucormycosis-a neurological prospective.
Egypt J Neurol Psychiatr Neurosurg
; 57(1): 100, 2021.
Article
in English
| MEDLINE | ID: covidwho-1327953
ABSTRACT
BACKGROUND:
Direct neurological manifestations of coronavirus disease whether peripheral or central are reported worldwide. Yet, along the 3rd wave of the pandemic especially in India, an associated angioinvasive opportunistic infection with mucormycosis in COVID-19 cases is emerging. CASE PRESENTATION The current case series which represents 4 patients with mucormycosis post COVID-19 is one of a few if not the first case series that discusses post COVID-19 mucormycosis from a neurological prospective in a tertiary hospital in Egypt.All cases but one presented with total ophthalmoplegia, and only one was diagnosed as a cavernous sinus thrombosis; meanwhile, orbital cellulitis and orbital apex syndrome were responsible of ophthalmoplegia in two cases.Mortality reached 25%, and the case that died suffered cutaneous as well as rhino-cerebral type with a delayed presentation to hospital.CONCLUSION:
A rare but fatal fungal infection is ought to be nowadays kept in mind in COVID-19 active cases as well as in recovered COVID-19 patients, especially those who have comorbid medical conditions as uncontrolled diabetes and who were treated with large doses of corticosteroids.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Case report
/
Observational study
/
Prognostic study
Topics:
Long Covid
Language:
English
Journal:
Egypt J Neurol Psychiatr Neurosurg
Year:
2021
Document Type:
Article
Affiliation country:
S41983-021-00355-8
Similar
MEDLINE
...
LILACS
LIS